{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T11:22:22Z","timestamp":1771413742266,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI15\/00190"],"award-info":[{"award-number":["PI15\/00190"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005774","name":"Universitat de Barcelona","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005774","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Cardiovasc. Transl. Res."],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Individuals with severe obesity (SO) are at a high risk of developing cardiovascular disease, but traditional lipid parameters are insufficient for accurately assessing the risk. This study aims to investigate the advanced characteristics of lipoproteins that may contribute to subclinical atherosclerosis in SO and the impact of bariatric surgery (BS). The study included 37 patients with SO with a one-year follow-up post-BS, and 40 control subjects. Advanced lipoprotein profiles were assessed using nuclear magnetic resonance. BS normalized proatherogenic lipoprotein alterations in SO. Small LDL and medium HDL particle numbers differed between plaque and non-plaque groups. A ratio of these particles showed an AUC of 83%, suggesting it could effectively predict subclinical atherosclerosis. Advanced NMR analysis offers more specific information on lipid profiles in SO. The small LDL-P to medium HDL-P ratio could be a valuable tool for detecting and managing subclinical atherosclerosis in this population.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical Abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1007\/s12265-025-10696-x","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T15:45:09Z","timestamp":1761752709000},"page":"1805-1817","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A Potential Ratio for Detecting Subclinical Atherosclerosis: Insight into Advanced NMR Lipid Profiles in Severe Obesity"],"prefix":"10.1007","volume":"18","author":[{"given":"J\u00falia","family":"Carmona-Maurici","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iratxe","family":"Eskubi-Turr\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Vi\u00f1as","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Ricart-Jan\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00aa Dolores","family":"L\u00f3pez-Tejero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N\u00faria","family":"Amig\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelino","family":"Berm\u00fadez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Antonio","family":"Baena-Fustegueras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Peinado-Onsurbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0588-1324","authenticated-orcid":false,"given":"Eva","family":"Pardina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"key":"10696_CR1","doi-asserted-by":"publisher","unstructured":"Moini J, Ahangari R, Miller C, Samsam M. Chapter 18 - Perspective on economics and obesity. In: Moini J, Ahangari R, Miller C, Samsam MBT-GHC of O, editors., Elsevier; 2020, p. 411\u201323. https:\/\/doi.org\/10.1016\/B978-0-12-819751-6.00018-9.","DOI":"10.1016\/B978-0-12-819751-6.00018-9"},{"key":"10696_CR2","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1016\/j.jacc.2008.12.068","volume":"53","author":"CJ Lavie","year":"2009","unstructured":"Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol. 2009;53:1925\u201332. https:\/\/doi.org\/10.1016\/j.jacc.2008.12.068.","journal-title":"J Am Coll Cardiol"},{"key":"10696_CR3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.metabol.2018.11.005","volume":"92","author":"J Vekic","year":"2019","unstructured":"Vekic J, Zeljkovic A, Stefanovic A, Jelic-Ivanovic Z, Spasojevic-Kalimanovska V. Obesity and dyslipidemia. Metabolism. 2019;92:71\u201381. https:\/\/doi.org\/10.1016\/j.metabol.2018.11.005.","journal-title":"Metabolism"},{"key":"10696_CR4","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1111\/j.1742-1241.2008.01804.x","volume":"62","author":"PP Toth","year":"2008","unstructured":"Toth PP. Subclinical atherosclerosis: what it is, what it means and what we can do about it. Int J Clin Pract. 2008;62:1246\u201354. https:\/\/doi.org\/10.1111\/j.1742-1241.2008.01804.x.","journal-title":"Int J Clin Pract"},{"key":"10696_CR5","first-page":"1898","volume":"45","author":"JR Davies","year":"2004","unstructured":"Davies JR, Rudd JH, Weissberg PL. Molecular and metabolic imaging of atherosclerosis. J Nucl Med. 2004;45:1898\u2013907.","journal-title":"J Nucl Med"},{"key":"10696_CR6","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1161\/CIRCRESAHA.115.307611","volume":"118","author":"W Herrington","year":"2016","unstructured":"Herrington W, Lacey B, Sherliker P, Armitage J, Lewington S. Epidemiology of atherosclerosis and the potential to reduce the global burden of atherothrombotic disease. Circ Res. 2016;118:535\u201346. https:\/\/doi.org\/10.1161\/CIRCRESAHA.115.307611.","journal-title":"Circ Res"},{"key":"10696_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-11-117","volume":"11","author":"J Frostegard","year":"2013","unstructured":"Frostegard J. Immunity, atherosclerosis and cardiovascular disease. BMC Med. 2013;11:117. https:\/\/doi.org\/10.1186\/1741-7015-11-117.","journal-title":"BMC Med"},{"issue":"1","key":"10696_CR8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"F Mach","year":"2020","unstructured":"Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111\u201388. https:\/\/doi.org\/10.1093\/eurheartj\/ehz455.","journal-title":"Eur Heart J"},{"key":"10696_CR9","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.hlc.2021.06.525","volume":"31","author":"K Ellenberger","year":"2022","unstructured":"Ellenberger K, Jeyaprakash P, Sivapathan S, Sangha S, Kitley J, Darshni A, et al. The effect of obesity on echocardiographic image quality. Heart Lung Circ. 2022;31:207\u201315. https:\/\/doi.org\/10.1016\/j.hlc.2021.06.525.","journal-title":"Heart Lung Circ"},{"key":"10696_CR10","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.arteri.2016.11.001","volume":"29","author":"JF Ascaso","year":"2017","unstructured":"Ascaso JF, Mill\u00e1n J, Hern\u00e1ndez-Mijares A, Blasco M, Brea \u00c1, D\u00edaz \u00c1, et al. Consensus document on the management of the atherogenic dyslipidaemia of the Spanish Society of Arteriosclerosis. Clin e Investig En Arterioscler Publ Of La Soc Esp Arterioscler. 2017;29:86\u201391. https:\/\/doi.org\/10.1016\/j.arteri.2016.11.001.","journal-title":"Clin e Investig En Arterioscler Publ Of La Soc Esp Arterioscler"},{"key":"10696_CR11","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1194\/jlr.D050120","volume":"56","author":"R Mallol","year":"2015","unstructured":"Mallol R, Amig\u00f3 N, Rodr\u00edguez MA, Heras M, Vinaixa M, Plana N, et al. Liposcale: a novel advanced lipoprotein test based on 2D diffusion-ordered 1H NMR spectroscopy. J Lipid Res. 2015;56:737\u201346. https:\/\/doi.org\/10.1194\/jlr.D050120.","journal-title":"J Lipid Res"},{"key":"10696_CR12","doi-asserted-by":"publisher","first-page":"e111926","DOI":"10.1371\/journal.pone.0111926","volume":"9","author":"L Niu","year":"2014","unstructured":"Niu L, Zhang Y, Meng L, Xiao Y, Wong KKL, Abbott D, et al. Detection of subclinical atherosclerosis in asymptomatic subjects using ultrasound radiofrequency-tracking technology. PLoS ONE. 2014;9:e111926.","journal-title":"PLoS ONE"},{"key":"10696_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12071180","volume":"12","author":"A Sofogianni","year":"2022","unstructured":"Sofogianni A, Stalikas N, Antza C, Tziomalos K. Cardiovascular risk prediction models and scores in the era of personalized medicine. J Pers Med. 2022;12:1180. https:\/\/doi.org\/10.3390\/jpm12071180.","journal-title":"J Pers Med"},{"key":"10696_CR14","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/j.soard.2020.05.035","volume":"16","author":"J Carmona-Maurici","year":"2020","unstructured":"Carmona-Maurici J, Cuello E, S\u00e1nchez E, Mi\u00f1arro A, Rius F, Bueno M, et al. Impact of bariatric surgery on subclinical atherosclerosis in patients with morbid obesity. Surg Obes Relat Dis. 2020;16:1419\u201328. https:\/\/doi.org\/10.1016\/j.soard.2020.05.035.","journal-title":"Surg Obes Relat Dis"},{"key":"10696_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fnume.2022.960522","author":"EU Emeasoba","year":"2022","unstructured":"Emeasoba EU, Ibeson E, Nwosu I, Montemarano N, Shani J, Shetty VS. Clinical relevance of nuclear magnetic resonance lipoprofile. Front Nucl Med. 2022. https:\/\/doi.org\/10.3389\/fnume.2022.960522.","journal-title":"Front Nucl Med"},{"key":"10696_CR16","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1080\/14728222.2019.1620206","volume":"23","author":"M Bermudez-Lopez","year":"2019","unstructured":"Bermudez-Lopez M, Forne C, Amigo N, Bozic M, Arroyo D, Bretones T, et al. An in-depth analysis shows a hidden atherogenic lipoprotein profile in non-diabetic chronic kidney disease patients. Expert Opin Ther Targets. 2019;23:619\u201330. https:\/\/doi.org\/10.1080\/14728222.2019.1620206.","journal-title":"Expert Opin Ther Targets"},{"key":"10696_CR17","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.artere.2020.04.001","volume":"32","author":"X Pint\u00f3","year":"2020","unstructured":"Pint\u00f3 X, Masana L, Civeira F, Real J, Ibarretxe D, Candas B, et al. Consensus document of an expert group from the Spanish Society of Arteriosclerosis (SEA) on the clinical use of nuclear magnetic resonance to assess lipoprotein metabolism (Liposcale\u00ae). Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis (English Edition). 2020;32:219\u201329. https:\/\/doi.org\/10.1016\/j.artere.2020.04.001.","journal-title":"Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis (English Edition)"},{"key":"10696_CR18","doi-asserted-by":"publisher","unstructured":"Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486\u201397. https:\/\/doi.org\/10.1001\/jama.285.19.2486.","DOI":"10.1001\/jama.285.19.2486"},{"key":"10696_CR19","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1093\/eurheartj\/ehab309","volume":"42","author":"SCORE2 risk prediction algorithms","year":"2021","unstructured":"SCORE2 risk prediction algorithms. new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J. 2021;42:2439\u201354. https:\/\/doi.org\/10.1093\/eurheartj\/ehab309.","journal-title":"Eur Heart J"},{"key":"10696_CR20","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1194\/jlr.D050120","volume":"56","author":"R Mallol","year":"2015","unstructured":"Mallol R, Amigo N, Rodriguez MA, Heras M, Vinaixa M, Plana N, et al. Liposcale: a novel advanced lipoprotein test based on 2D diffusion-ordered 1H NMR spectroscopy. J Lipid Res. 2015;56:737\u201346. https:\/\/doi.org\/10.1194\/jlr.D050120.","journal-title":"J Lipid Res"},{"key":"10696_CR21","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.cll.2006.07.006","volume":"26","author":"EJ Jeyarajah","year":"2006","unstructured":"Jeyarajah EJ, Cromwell WC, Otvos JD. Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy. Clin Lab Med. 2006;26:847\u201370. https:\/\/doi.org\/10.1016\/j.cll.2006.07.006.","journal-title":"Clin Lab Med"},{"key":"10696_CR22","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"F Mach","year":"2020","unstructured":"Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). Eur Heart J. 2020;41:111\u201388. https:\/\/doi.org\/10.1093\/eurheartj\/ehz455.","journal-title":"Eur Heart J"},{"key":"10696_CR23","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","volume":"42","author":"FLJ Visseren","year":"2021","unstructured":"Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, B\u00e4ck M, et al. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice: developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies with. Eur Heart J. 2021;42:3227\u2013337. https:\/\/doi.org\/10.1093\/eurheartj\/ehab484.","journal-title":"Eur Heart J"},{"key":"10696_CR24","unstructured":"Feingold KR, Grunfeld C. Utility of Advanced Lipoprotein Testing in Clinical Practice. In: Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dungan K, et al., editors., South Dartmouth (MA): 2000."},{"key":"10696_CR25","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1172\/JCI107334","volume":"52","author":"JD Brunzell","year":"1973","unstructured":"Brunzell JD, Hazzard WR, Porte DJ, Bierman EL. Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man. J Clin Invest. 1973;52:1578\u201385. https:\/\/doi.org\/10.1172\/JCI107334.","journal-title":"J Clin Invest"},{"issue":"3","key":"10696_CR26","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1093\/ajcn\/77.3.573","volume":"77","author":"B Mittendorfer","year":"2003","unstructured":"Mittendorfer B, Patterson BW, Klein S. Effect of sex and obesity on basal VLDL-triacylglycerol kinetics. Am J Clin Nutr. 2003;77(3):573\u20139. https:\/\/doi.org\/10.1093\/ajcn\/77.3.573.","journal-title":"Am J Clin Nutr"},{"key":"10696_CR27","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2217\/clp.12.9","volume":"7","author":"R Al-Zoairy","year":"2012","unstructured":"Al-Zoairy R, Melmer A, Ress C, Laimer M, Kaser S, Ebenbichler C. Lipid profile changes after pronounced weight loss induced by bariatric surgery. Clin Lipidol. 2012;7:163\u201375. https:\/\/doi.org\/10.2217\/clp.12.9.","journal-title":"Clin Lipidol"},{"key":"10696_CR28","doi-asserted-by":"publisher","DOI":"10.1097\/01.mol.0000226115.97436.c0","author":"M Adiels","year":"2006","unstructured":"Adiels M, Olofsson S-O, Taskinen M-R, Bor\u00e9n J. Diabetic dyslipidaemia. Curr Opin Lipidol. 2006. https:\/\/doi.org\/10.1097\/01.mol.0000226115.97436.c0.","journal-title":"Curr Opin Lipidol"},{"key":"10696_CR29","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.jacl.2013.04.001","volume":"7","author":"HE Bays","year":"2013","unstructured":"Bays HE, Toth PP, Kris-Etherton PM, Abate N, Aronne LJ, Brown WV, et al. Obesity, adiposity, and dyslipidemia: a consensus statement from the National Lipid Association. J Clin Lipidol. 2013;7:304\u201383.","journal-title":"J Clin Lipidol"},{"key":"10696_CR30","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1001\/jama.292.14.1724","volume":"292","author":"H Buchwald","year":"2004","unstructured":"Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724\u201337. https:\/\/doi.org\/10.1001\/jama.292.14.1724.","journal-title":"JAMA"},{"key":"10696_CR31","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1016\/j.amjcard.2011.06.076","volume":"108","author":"HM Heneghan","year":"2011","unstructured":"Heneghan HM, Meron-Eldar S, Brethauer SA, Schauer PR, Young JB. Effect of bariatric surgery on cardiovascular risk profile. AmJCardiol. 2011;108:1499\u2013507.","journal-title":"AmJCardiol"},{"key":"10696_CR32","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1194\/jlr.P900015","volume":"51","author":"BF Asztalos","year":"2010","unstructured":"Asztalos BF, Swarbrick MM, Schaefer EJ, Dallal GE, Horvath KV, Ai M, et al. Effects of weight loss, induced by gastric bypass surgery, on HDL remodeling in obese women. J Lipid Res. 2010;51:2405\u201312. https:\/\/doi.org\/10.1194\/jlr.P900015.","journal-title":"J Lipid Res"},{"key":"10696_CR33","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.soard.2010.08.009","volume":"7","author":"M Jamal","year":"2011","unstructured":"Jamal M, Wegner R, Heitshusen D, Liao J, Samuel I. Resolution of hyperlipidemia follows surgical weight loss in patients undergoing Roux-en-Y gastric bypass surgery: a 6-year analysis of data. Surg Obes Relat Dis. 2011;7:473\u20139. https:\/\/doi.org\/10.1016\/j.soard.2010.08.009.","journal-title":"Surg Obes Relat Dis"},{"key":"10696_CR34","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1097\/HCO.0000000000000410","volume":"32","author":"PA Gerber","year":"2017","unstructured":"Gerber PA, Nikolic D, Rizzo M. Small, dense LDL: an update. Curr Opin Cardiol. 2017;32:454\u20139. https:\/\/doi.org\/10.1097\/HCO.0000000000000410.","journal-title":"Curr Opin Cardiol"},{"key":"10696_CR35","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1194\/jlr.r200004-jlr200","volume":"43","author":"KK Berneis","year":"2002","unstructured":"Berneis KK, Krauss RM. Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res. 2002;43:1363\u201379. https:\/\/doi.org\/10.1194\/jlr.r200004-jlr200.","journal-title":"J Lipid Res"},{"key":"10696_CR36","doi-asserted-by":"publisher","unstructured":"Toth PP. Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease. Vasc Health Risk Manag. 2016;12:171\u201383. https:\/\/doi.org\/10.2147\/VHRM.S104369.","DOI":"10.2147\/VHRM.S104369"},{"key":"10696_CR37","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/j.soard.2020.04.040","volume":"16","author":"J Carmona-Maurici","year":"2020","unstructured":"Carmona-Maurici J, Cuello E, Ricart-Jan\u00e9 D, Mi\u00f1arro A, Olsina Kissler JJ, Baena-Fustegueras JA, et al. Effect of bariatric surgery in the evolution of oxidative stress depending on the presence of atheroma in patients with morbid obesity. Surg Obes Relat Dis. 2020;16:1258\u201365. https:\/\/doi.org\/10.1016\/j.soard.2020.04.040.","journal-title":"Surg Obes Relat Dis"},{"key":"10696_CR38","doi-asserted-by":"publisher","first-page":"178","DOI":"10.2337\/dc19-0772","volume":"43","author":"T Vaisar","year":"2020","unstructured":"Vaisar T, Kanter JE, Wimberger J, Irwin AD, Gauthier J, Wolfson E, et al. High concentration of medium-sized HDL particles and enrichment in HDL paraoxonase 1 associate with protection from vascular complications in people with long-standing type 1 diabetes. Diabetes Care. 2020;43:178\u201386. https:\/\/doi.org\/10.2337\/dc19-0772.","journal-title":"Diabetes Care"},{"key":"10696_CR39","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/1476-511X-10-176","volume":"10","author":"H Wang","year":"2011","unstructured":"Wang H, Peng D-Q. New insights into the mechanism of low high-density lipoprotein cholesterol in obesity. Lipids Health Dis. 2011;10:176. https:\/\/doi.org\/10.1186\/1476-511X-10-176.","journal-title":"Lipids Health Dis"},{"key":"10696_CR40","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3389\/fcvm.2020.00039","volume":"7","author":"A Jomard","year":"2020","unstructured":"Jomard A, Osto E. High density lipoproteins: metabolism, function, and therapeutic potential. Front Cardiovasc Med. 2020;7:39. https:\/\/doi.org\/10.3389\/fcvm.2020.00039.","journal-title":"Front Cardiovasc Med"},{"key":"10696_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2007.342","author":"S Rashid","year":"2007","unstructured":"Rashid S, Genest J. Effect of obesity on high-density lipoprotein metabolism. Obesity. 2007. https:\/\/doi.org\/10.1038\/oby.2007.342.","journal-title":"Obesity"},{"key":"10696_CR42","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/s11695-019-04126-6","volume":"30","author":"OH Nienov","year":"2020","unstructured":"Nienov OH, Machado FD, Dias LS, De Carli LA, Schmid H. Effect of bariatric surgery on high-density lipoprotein (HDL) cholesterol in non-diabetic patients with severe obesity. Obes Surg. 2020;30:154\u201360. https:\/\/doi.org\/10.1007\/s11695-019-04126-6.","journal-title":"Obes Surg"},{"key":"10696_CR43","unstructured":"Feingold KR, Grunfeld C. Introduction to lipids and lipoproteins. In: Feingold KR, Anawalt B, Boyce A, Chrousos G, Dungan K, Grossman A, et al., editors., South Dartmouth (MA): 2000."},{"key":"10696_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24065391","author":"A Cordero","year":"2023","unstructured":"Cordero A, Mu\u00f1oz-Garc\u00eda N, Padr\u00f3 T, Vilahur G, Bertomeu-Gonz\u00e1lez V, Escribano D, et al. HDL function and size in patients with on-target LDL plasma levels and a first-onset ACS. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24065391.","journal-title":"Int J Mol Sci"},{"key":"10696_CR45","doi-asserted-by":"crossref","unstructured":"Parra ES, Panzoldo NB, Zago VH de S, Scherrer DZ, Alexandre F, Bakkarat J, et al. HDL Size is more accurate than HDL cholesterol to predict carotid subclinical atherosclerosis in individuals classified as low cardiovascular risk. PLoS One 2014;9:e114212.","DOI":"10.1371\/journal.pone.0114212"},{"key":"10696_CR46","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.jacc.2017.12.006","volume":"71","author":"MV Holmes","year":"2018","unstructured":"Holmes MV, Millwood IY, Kartsonaki C, Hill MR, Bennett DA, Boxall R, et al. Lipids, lipoproteins, and metabolites and risk of myocardial infarction and stroke. J Am Coll Cardiol. 2018;71:620\u201332. https:\/\/doi.org\/10.1016\/j.jacc.2017.12.006.","journal-title":"J Am Coll Cardiol"},{"key":"10696_CR47","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.jacc.2012.03.060","volume":"60","author":"RH Mackey","year":"2012","unstructured":"Mackey RH, Greenland P, Goff DC Jr, Lloyd-Jones D, Sibley CT, Mora S. High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (multi-ethnic study of atherosclerosis). J Am Coll Cardiol. 2012;60:508\u201316. https:\/\/doi.org\/10.1016\/j.jacc.2012.03.060.","journal-title":"J Am Coll Cardiol"},{"key":"10696_CR48","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1161\/CIRCULATIONAHA.113.002671","volume":"128","author":"S Mora","year":"2013","unstructured":"Mora S, Glynn RJ, Ridker PM. High-density lipoprotein cholesterol, size, particle number, and residual vascular risk after potent statin therapy. Circulation. 2013;128:1189\u201397. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.002671.","journal-title":"Circulation"},{"key":"10696_CR49","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1161\/CIRCRESAHA.116.308357","volume":"119","author":"JS Monette","year":"2016","unstructured":"Monette JS, Hutchins PM, Ronsein GE, Wimberger J, Irwin AD, Tang C, et al. Patients with coronary endothelial dysfunction have impaired cholesterol efflux capacity and reduced HDL particle concentration. Circ Res. 2016;119:83\u201390. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.308357.","journal-title":"Circ Res"},{"key":"10696_CR50","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1093\/eurheartj\/ehv428","volume":"36","author":"N Townsend","year":"2015","unstructured":"Townsend N, Nichols M, Scarborough P, Rayner M. Cardiovascular disease in Europe \u2014 epidemiological update 2015. Eur Heart J. 2015;36:2696\u2013705. https:\/\/doi.org\/10.1093\/eurheartj\/ehv428.","journal-title":"Eur Heart J"}],"container-title":["Journal of Cardiovascular Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-025-10696-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12265-025-10696-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-025-10696-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T14:19:31Z","timestamp":1765549171000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12265-025-10696-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10696"],"URL":"https:\/\/doi.org\/10.1007\/s12265-025-10696-x","relation":{},"ISSN":["1937-5387","1937-5395"],"issn-type":[{"value":"1937-5387","type":"print"},{"value":"1937-5395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,29]]},"assertion":[{"value":"24 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in the studies involving human participants were in accordance with the standards of the ethics committee of Arnau de Vilanova University Hospital \u201cComit\u00e8 d\u2019\u00c8tica d\u2019Investigaci\u00f3 amb Medicaments, Hospital Universitari Arnau de Vilanova Lleida\u201d, project number \"CEIC-1369\". Furthermore, they complied with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. Informed consent was obtained from all patients for being included in the study. No animal studies were carried out by the authors for this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"NA is a shareholder of Biosfer Teslab, the company that commercializes the lipoprotein profiling described in the present manuscript, and is one of the authors of the patented method. The other authors have no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}